Skip to main content
OpenTrials

Clinical trial condition

Relapsed Acute Myeloid Leukemia

Explore clinical trials studying Relapsed Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

11 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Relapsed Acute Myeloid Leukemia trial results

Recruiting

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

NCT06017258

Conditions
Acute Myeloid Leukemia, Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, +9 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Recruiting

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

NCT06177067

Conditions
Acute Leukemia of Ambiguous Lineage, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • Rady Children's Hospital San Diego, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Children's Mercy Hospital of Kansas City Kansas City, Missouri, United States
View Trial Details

Related conditions